Sort by
Refine Your Search
-
and research infrastructure makes UCL a global leader. Dr Nnenna Kanu is the Chief Scientific Officer of the Cancer Research UK Lung Cancer centre of Excellence. The Kanu Lab is a multi-disciplinary
-
limited to: Assess therapeutic response in primary CRC organoids in vitro and implanted tumours in vivo Loss-of-functional whole-genome/sub-genome CRISPR screen in vitro and in vivo to reveal treatment
-
molecular cloning and animal models is essential. The post holder will join a team of scientists at ICH as well as linking with the collaborating groups at the partner Institutions in the collaboration. Main
-
cortical atrophy (PCA), primary progressive aphasia (PPA), behavioural variant frontotemporal dementia (bvFTD), and people living at-risk of inheriting frontotemporal dementia (fFTD) or Alzheimer’s disease
-
postdoctoral fellow roles, suitable for early career researchers who are at the point of completing their PhD or who have recently completed their PhD. The appointed Fellows will work with the project Principal
-
improvements in cancer patient care. BCI is also a partner in the CRUK City of London Major Centre (together with UCL, Kings and the Francis Crick Institute) which is a Centre of Excellence in Biotherapeutics
-
improvements in cancer patient care. BCI is also a partner in the CRUK City of London Major Centre (together with UCL, Kings and the Francis Crick Institute) which is a Centre of Excellence in Biotherapeutics
-
across the University of Oslo, industry partners and University College London (UCL). The successful candidate will work with and further develop the electricity system model highRES to analyse the role